Study no. TVP-1012/PM106: A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients with Parkinson's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date1/14/13 → 1/14/16

Funding

  • INC Research, LLC (TVP-1012/PM106 // TVP-1012/PM106)
  • Teva Neuroscience, Inc. (TVP-1012/PM106 // TVP-1012/PM106)